We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$36.3B
AUM Growth
+$2.54B
Cap. Flow
+$1.28B
Cap. Flow %
3.53%
Top 10 Hldgs %
14.85%
Holding
3,030
New
42
Increased
2,539
Reduced
264
Closed
157

Top Buys

Rank Stock Value
1
CHTR icon
Charter Communications
CHTR
+$34.8M
2
AAPL icon
Apple
AAPL
+$33.7M
3
XOM icon
ExxonMobil
XOM
+$30M
4
MSFT icon
Microsoft
MSFT
+$25.3M
5
FTV icon
Fortive
FTV
+$24.2M

Sector Composition

Rank Sector Weight
1 Technology 14.71%
2 Financials 14.59%
3 Healthcare 13.89%
4 Industrials 10.54%
5 Consumer Discretionary 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LFVN icon
2776
LifeVantage
LFVN
$81.1M
$127K ﹤0.01%
13,411
+2,180
+19% +$28.3K
TNDM icon
2777
Tandem Diabetes Care
TNDM
$1.34B
$127K ﹤0.01%
1,654
+22
+1% +$1.6K
TRAK icon
2778
ReposiTrak
TRAK
$153M
$127K ﹤0.01%
10,724
+400
+4% +$4.08K
PZN
2779
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$127K ﹤0.01%
16,429
+200
+1% +$1.54K
VYGR icon
2780
Voyager Therapeutics
VYGR
$183M
$126K ﹤0.01%
+10,451
New +$141K
WAC
2781
DELISTED
Walter Investment Mgt Corp
WAC
$125K ﹤0.01%
30,897
-1,029
-3% -$3.24K
GUID
2782
DELISTED
Guidance Software, Inc.
GUID
$125K ﹤0.01%
21,000
+500
+2% +$2.97K
FLNT
2783
Fluent
FLNT
$102M
$124K ﹤0.01%
4,052
+700
+21% +$21.5K
JMBA
2784
DELISTED
Jamba, Inc.
JMBA
$124K ﹤0.01%
11,342
+20
+0.2% +$215
IBRX icon
2785
ImmunityBio
IBRX
$7.51B
$123K ﹤0.01%
15,865
+400
+3% +$2.99K
NWHM
2786
DELISTED
THE NEW HOME COMPANY INC.
NWHM
$123K ﹤0.01%
11,557
+300
+3% +$2.99K
JONE
2787
DELISTED
Jones Energy, Inc.
JONE
$123K ﹤0.01%
1,878
+24
+1% +$1.48K
RGLS
2788
DELISTED
Regulus Therapeutics
RGLS
$120K ﹤0.01%
304
+6
+2% +$2.47K
FRBK
2789
DELISTED
Republic First Bancorp Inc
FRBK
$120K ﹤0.01%
29,093
+5,300
+22% +$22.5K
NCIT
2790
DELISTED
NCI, Inc.
NCIT
$120K ﹤0.01%
+10,409
New +$130K
NGVC icon
2791
Vitamin Cottage Natural Grocers
NGVC
$739M
$117K ﹤0.01%
10,508
+30
+0.3% +$371
NAGE
2792
Niagen Bioscience
NAGE
$271M
$117K ﹤0.01%
39,401
+6,500
+20% +$23.9K
BPTH
2793
DELISTED
Bio-Path Holdings Inc
BPTH
$117K ﹤0.01%
21
+3
+17% +$19.3K
LRMR icon
2794
Larimar Therapeutics
LRMR
$397M
$116K ﹤0.01%
2,916
+25
+0.9% +$1.14K
PFSW
2795
DELISTED
PFSweb, Inc.
PFSW
$114K ﹤0.01%
12,723
+200
+2% +$1.94K
AGTC
2796
DELISTED
Applied Genetic Technologies Corporation
AGTC
$112K ﹤0.01%
11,452
+385
+3% +$5.19K
ALJJ
2797
DELISTED
ALJ Regional Holdings Inc
ALJJ
$112K ﹤0.01%
23,794
+4,900
+26% +$23.3K
WNEB icon
2798
Western New England Bancorp
WNEB
$259M
$111K ﹤0.01%
14,573
+400
+3% +$3.07K
FCFP
2799
DELISTED
FIRST COMMUNITY FINANCIAL PARTNERS INC.
FCFP
$109K ﹤0.01%
+11,460
New +$104K
LIND icon
2800
Lindblad Expeditions
LIND
$1.94B
$108K ﹤0.01%
12,041
+400
+3% +$3.77K

Similar funds

RhumbLine Advisers's Q3 2016 Portfolio in Review

As of Q3 2016, RhumbLine Advisers held 3,030 positions worth $36.3B, up 7.5% from $33.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers deployed $1.28B of net new capital in Q3 2016, opening 42 new positions and adding to 2,539 existing holdings. Its largest new stake was Fortive: 753,372 shares worth $24.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Danaher, an estimated $24.4M trimmed.

  • RhumbLine Advisers's largest Q3 2016 buy was Fortive: 753,372 shares worth $24.2M.
  • RhumbLine Advisers added most to Charter Communications in Q3 2016, an estimated $34.8M increase.
  • RhumbLine Advisers's biggest Q3 2016 reduction was Danaher, cutting an estimated $24.4M.
  • RhumbLine Advisers fully exited EMC CORPORATION in Q3 2016, selling an estimated $81.1M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $36.3B portfolio in Q3 2016.
  • RhumbLine Advisers opened 42 new positions and closed 157 in Q3 2016.
  • RhumbLine Advisers's portfolio value rose 7.5% quarter-over-quarter to $36.3B.

Based on RhumbLine Advisers's 13F filing for Q3 2016, filed 8 Nov 2016.